An epitope-specific LGI1-autoantibody enhances neuronal excitability by modulating Kv1.1 channel
Leucine-rich Glioma-Inactivated protein 1 (LGI1) is expressed in the central nervous system and its genetic loss of function is associated with epileptic disorders. Additionally, patients with LGI1-directed autoantibodies have frequent focal seizures as a key feature of their disease. LGI1 is compos...
Hoofdauteurs: | Extrémet, J, El Far, O, Ankri, N, Irani, SR, Debanne, D, Russier, M |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
MDPI
2022
|
Gelijkaardige items
-
An Epitope-Specific LGI1-Autoantibody Enhances Neuronal Excitability by Modulating Kv1.1 Channel
door: Johanna Extrémet, et al.
Gepubliceerd in: (2022-08-01) -
CXCL13 levels and autoantibody epitope specificities in LGI1-autoantibody syndromes
door: Michael, S, et al.
Gepubliceerd in: (2019) -
Patient-derived antibodies reveal the subcellular distribution and heterogeneous interactome of LGI1
door: Ramirez-Franco, J, et al.
Gepubliceerd in: (2022) -
CXCL13 levels in LGI1-and CASPR2-autoantibody syndromes
door: Michael, S, et al.
Gepubliceerd in: (2019) -
Stop testing for autoantibodies to the VGKC-complex: only request LGI1 and CASPR2
door: Michael, S, et al.
Gepubliceerd in: (2020)